Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_2
1
7%
Ph phase_3
2
14%
Ph phase_4
5
36%
Ph phase_1
3
21%
Ph not_applicable
3
21%

Phase Distribution

3

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
3(21.4%)
Phase 2Efficacy & side effects
1(7.1%)
Phase 3Large-scale testing
2(14.3%)
Phase 4Post-market surveillance
5(35.7%)
N/ANon-phased studies
3(21.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Completed(3)
Terminated(2)
Other(9)

Detailed Status

unknown9
Completed3
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (21.4%)
Phase 21 (7.1%)
Phase 32 (14.3%)
Phase 45 (35.7%)
N/A3 (21.4%)

Trials by Status

completed321%
terminated17%
unknown964%
withdrawn17%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT06646328Phase 4

Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.

Terminated
NCT04743011Phase 1

Enriched Heparin Anti COVID-19 Trial

Completed
NCT05749393Not Applicable

Effect of Different Heparinization Schemes on Prognosis of Intracranial Aneurysm

Unknown
NCT02654561Phase 3

Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation

Unknown
NCT05697692Phase 4

Heparin-free Extracorporeal Membrane Oxygenation Support During Clinical Lung Transplantation

Unknown
NCT05602129Phase 2

A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects

Unknown
NCT04767113Not Applicable

Continuous Heparin Infusion to Prevent Catheter-related Thrombosis

Completed
NCT03707418Phase 1

Bivalirudin vs Heparin in ECMO Patients

Withdrawn
NCT04530578Phase 4

Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19

Unknown
NCT02206087Phase 1

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin

Completed
NCT03539718Phase 4

Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters.

Unknown
NCT03306836Not Applicable

Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2

Unknown
NCT03113708Phase 4

The Effect of Heparinization Due to LBW

Unknown
NCT01346215Phase 3

Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure

Unknown

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14